Der geriatrische Parkinson-Patient - eine neurologische Herausforderung

P. Lingor; I. Csoti; J. Koschel; C. Schrader; C. Winkler; M. Wolz; H. Reichmann

doi:10.1055/s-0042-103585

Der geriatrische Parkinson-Patient - eine neurologische Herausforderung

Translated title of the contribution: The Geriatric Patient with Parkinson's Disease - A Neurological Challenge

P. Lingor, I. Csoti, J. Koschel, C. Schrader, C. Winkler, M. Wolz, H. Reichmann

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Geriatric patients with Parkinson's disease (PD) represent a particular challenge in terms of diagnostics and treatment. This overview article addresses age-related characteristics of this patient group and discusses particularities in PD symptoms in this age group, frequent comorbidities and the resulting polypharmacy. Questions regarding the availability of specialist and therapist care as well as end-of-life aspects are discussed. While comprehensive care structures are not always available, this patient group requires a multidisciplinary treatment team supervised by neurologists with ample experience in PD treatment.

Translated title of the contribution	The Geriatric Patient with Parkinson's Disease - A Neurological Challenge
Original language	German
Pages (from-to)	S41-S47
Journal	Fortschritte der Neurologie Psychiatrie
Volume	84
DOIs	https://doi.org/10.1055/s-0042-103585
State	Published - 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1055/s-0042-103585

Cite this

@article{63e789b0e01f464cb9d26279da176f66,

title = "Der geriatrische Parkinson-Patient - eine neurologische Herausforderung",

abstract = "Geriatric patients with Parkinson's disease (PD) represent a particular challenge in terms of diagnostics and treatment. This overview article addresses age-related characteristics of this patient group and discusses particularities in PD symptoms in this age group, frequent comorbidities and the resulting polypharmacy. Questions regarding the availability of specialist and therapist care as well as end-of-life aspects are discussed. While comprehensive care structures are not always available, this patient group requires a multidisciplinary treatment team supervised by neurologists with ample experience in PD treatment.",

keywords = "Parkinson's disease, comorbidity, end-of-life, geriatrics, health care, polypharmacy",

author = "P. Lingor and I. Csoti and J. Koschel and C. Schrader and C. Winkler and M. Wolz and H. Reichmann",

note = "Publisher Copyright: {\textcopyright} Georg Thieme Verlag KG Stuttgart New York.",

year = "2016",

doi = "10.1055/s-0042-103585",

language = "Deutsch",

volume = "84",

pages = "S41--S47",

journal = "Fortschritte der Neurologie Psychiatrie",

issn = "0720-4299",

publisher = "Georg Thieme Verlag",

}

TY - JOUR

T1 - Der geriatrische Parkinson-Patient - eine neurologische Herausforderung

AU - Lingor, P.

AU - Csoti, I.

AU - Koschel, J.

AU - Schrader, C.

AU - Winkler, C.

AU - Wolz, M.

AU - Reichmann, H.

N1 - Publisher Copyright: © Georg Thieme Verlag KG Stuttgart New York.

PY - 2016

Y1 - 2016

N2 - Geriatric patients with Parkinson's disease (PD) represent a particular challenge in terms of diagnostics and treatment. This overview article addresses age-related characteristics of this patient group and discusses particularities in PD symptoms in this age group, frequent comorbidities and the resulting polypharmacy. Questions regarding the availability of specialist and therapist care as well as end-of-life aspects are discussed. While comprehensive care structures are not always available, this patient group requires a multidisciplinary treatment team supervised by neurologists with ample experience in PD treatment.

AB - Geriatric patients with Parkinson's disease (PD) represent a particular challenge in terms of diagnostics and treatment. This overview article addresses age-related characteristics of this patient group and discusses particularities in PD symptoms in this age group, frequent comorbidities and the resulting polypharmacy. Questions regarding the availability of specialist and therapist care as well as end-of-life aspects are discussed. While comprehensive care structures are not always available, this patient group requires a multidisciplinary treatment team supervised by neurologists with ample experience in PD treatment.

KW - Parkinson's disease

KW - comorbidity

KW - end-of-life

KW - geriatrics

KW - health care

KW - polypharmacy

UR - http://www.scopus.com/inward/record.url?scp=84973649614&partnerID=8YFLogxK

U2 - 10.1055/s-0042-103585

DO - 10.1055/s-0042-103585

M3 - Artikel

C2 - 27276072

AN - SCOPUS:84973649614

SN - 0720-4299

VL - 84

SP - S41-S47

JO - Fortschritte der Neurologie Psychiatrie

JF - Fortschritte der Neurologie Psychiatrie

ER -

Der geriatrische Parkinson-Patient - eine neurologische Herausforderung

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this